Gene · 5603
Papers1,919
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,919
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Proteomic characterization of the colorectal cancer response to chemoradiation and targeted therapies reveals potential therapeutic strategies. | Cell Rep Med | 2023 | 38086380 | PubTator, text mining | PubMed |
| The dysregulation of immune cells induced by uric acid: mechanisms of inflammation associated with hyperuricemia and its complications. | Front Immunol | 2023 | 38053999 | PubTator, text mining | PubMed |
| Musashi-2 Deficiency Triggers Colorectal Cancer Ferroptosis by Downregulating the MAPK Signaling Cascade to Inhibit HSPB1 Phosphorylation. | Biol Proced Online | 2023 | 38041016 | PubTator, text mining | PubMed |
| Structural basis of a redox-dependent conformational switch that regulates the stress kinase p38α. | Nat Commun | 2023 | 38040726 | PubTator, text mining | PubMed |
| Network pharmacology-based approach to investigate the molecular targets of essential oil obtained from lavender for treating breast cancer. | Heliyon | 2023 | 38034788 | PubTator, text mining | PubMed |
| The physiological functions and therapeutic potential of exosomes during the development and treatment of polycystic ovary syndrome. | Front Physiol | 2023 | 38028777 | PubTator, text mining | PubMed |
| FBXL19 promotes malignant behaviours by activating MAPK signalling and negatively correlates with prognosis in hepatocellular carcinoma. | Heliyon | 2023 | 38027627 | PubTator, text mining | PubMed |
| Lung Science Conference highlights 2023: Post-viral lung diseases - from basic immunology to clinical phenotypes and therapy. | Breathe (Sheff) | 2023 | 38020340 | PubTator, text mining | PubMed |
| The Essential Oil from Conyza bonariensis (L.) Cronquist (Asteraceae) Exerts an In Vitro Antimelanoma Effect by Inducing Apoptosis and Modulating the MAPKs, NF-κB, and PKB/AKT Signaling Pathways. | Pharmaceuticals (Basel) | 2023 | 38004419 | PubTator, text mining | PubMed |
| Kinase Signaling in Colitis-Associated Colon Cancer and Inflammatory Bowel Disease. | Biomolecules | 2023 | 38002302 | PubTator, text mining | PubMed |
| Analysis of Structural Changes in the Protein near the Phosphorylation Site. | Biomolecules | 2023 | 38002246 | PubTator, text mining | PubMed |
| Unveiling the potential effects of acetylsalicylic acid: insights into regeneration in endometrial stem cells. | Cell Commun Signal | 2023 | 37950232 | PubTator, text mining | PubMed |
| SARS-CoV-2 and the DNA damage response. | J Gen Virol | 2023 | 37948194 | PubTator, text mining | PubMed |
| p38 MAPK signaling in chronic obstructive pulmonary disease pathogenesis and inhibitor therapeutics. | Cell Commun Signal | 2023 | 37919729 | PubTator, text mining | PubMed |
| Association of Promoter Methylation Patterns with Expression of MAPK14 in Tissue of Papillary Thyroid Cancer Patients. | Asian Pac J Cancer Prev | 2023 | 37898857 | PubTator, text mining | PubMed |
| Gastric Cancer: Molecular Mechanisms, Novel Targets, and Immunotherapies: From Bench to Clinical Therapeutics. | Cancers (Basel) | 2023 | 37894443 | PubTator, text mining | PubMed |
| The Role of Cyclin-Dependent Kinases (CDK) 4/6 in the Ovarian Tissue and the Possible Effects of Their Exogenous Inhibition. | Cancers (Basel) | 2023 | 37894292 | PubTator, text mining | PubMed |
| The complex impact of cancer-related missense mutations on the stability and on the biophysical and biochemical properties of MAPK1 and MAPK3 somatic variants. | Hum Genomics | 2023 | 37891694 | PubTator, text mining | PubMed |
| Systematic P2Y receptor survey identifies P2Y11 as modulator of immune responses and virus replication in macrophages. | EMBO J | 2023 | 37881155 | PubTator, text mining | PubMed |
| Inhibition of SQSTM1 S403 phosphorylation facilitates the aggresome formation of ubiquitinated proteins during proteasome dysfunction. | Cell Mol Biol Lett | 2023 | 37872526 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5603/papers?page=6